CLINICAL SUPPLY MANAGEMENT ARTICLES
Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
Tariffs and geopolitical disruptions are reshaping supply chains. Companies must act now to strengthen continuity planning, evaluate tariff recovery opportunities, and build more resilient logistics strategies for the future.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
-
Explore how scenario planning enables you to find the best strategy while balancing risks and costs and gives you the ability to arm your internal stakeholders with impact assessment data based on plausible scenarios.